Written by Steven HansenThe U.S. new cases 7-day rolling average are 21.3 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 3.4 % LOWER than the rolling average one week ago. Today s posts include:
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking I agree you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our Cookie Settings . Please view our Cookie Policy to learn more about the use of cookies on our website.
Manage your cookiesI agree
Cookie Settings
Cookie Settings
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookie
The early immune response in a person who has been vaccinated for COVID-19 can predict the level of protection they will have to the virus over time, according to analysis from Australian mathematicians, clinicians, and scientists, and published the journal Nature Medicine. The researchers from the University of New South Wales s Kirby Institute, the Peter Doherty Institute for Infection and Immunity, and the University of Sydney have identified an immune correlate of vaccine protection. This has the potential to dramatically cut development times for new vaccines, by measuring neutralising antibody levels as a proxy for immune protection from COVID-19. Neutralising antibodies are tiny Y-shaped proteins produced by our body in response to infection or vaccination. They bind to the virus, reducing its ability to infect, says Dr Deborah Cromer from the Kirby Institute.
Researchers identify a new way to predict the efficacy of COVID-19 vaccines
The early immune response in a person who has been vaccinated for COVID-19 can predict the level of protection they will have to the virus over time, according to analysis from Australian mathematicians, clinicians, and scientists, and published today in
Nature Medicine.
The researchers from UNSW s Kirby Institute, the Peter Doherty Institute for Infection and Immunity, and the University of Sydney have identified an immune correlate of vaccine protection. This has the potential to dramatically cut development times for new vaccines, by measuring neutralising antibody levels as a proxy for immune protection from COVID-19.